Goldman Sachs’s Natus Medical Inc NTUS Stock Holding History

Goldman Sachs’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-32,300	Closed	-$1.23M	–	6513
2017 Q4	$1.23M	Buy	+32,300	New	+$1.29M	﹤0.01%	4170
2014 Q3	–	Sell	-50,000	Closed	-$1.26M	–	7321
2014 Q2	$1.26M	Hold	50,000	–	–	﹤0.01%	4476
2014 Q1	$1.29M	Buy	+50,000	New	+$1.26M	﹤0.01%	4419

Other funds holding NTUS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Goldman Sachs's NTUS Position: Q3 2022 in Review

Goldman Sachs sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 294,571 shares — an estimated $9.65M sold.

Goldman Sachs first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $17.5M in Q2 2021. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

Goldman Sachs reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
Goldman Sachs sold 294,571 Natus Medical Inc shares in Q3 2022, an estimated $9.65M.
Goldman Sachs first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
Goldman Sachs's Natus Medical Inc position peaked at $17.5M in Q2 2021.
1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.